Skip to main content

Table 2 Adverse effects in patients with COVID-19 by patient group

From: Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study

  LPV/r group (n = 22) Combination group (n = 19) P-value
Decreased white blood cell count, n (%) 3 (13.6) 3 (15.8) 1.000
Elevated transaminase, n (%) 6 (27.3) 5 (26.3) 0.945
Mild anemia, n (%) 2 (9) 0 (0) 0.490
Transient fever, n (%) 1 (4.5) 3 (15.8) 0.495
Digestive upsets, n (%) 6 (27.3) 5 (26.3) 0.945